RI
No verificado

RION

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud
21/01/2026
Ciencia
Medicina - Varios
Higiene alimentaria
Salud
Biología
Biotecnología
Farmacéutica
Industria
INTENT Biologics Receives FDA Agreement Granting a Full Waiver for its Pediatric Study Plan for PEP Biologic™ in Advanced Wound Care
Fuente
1.00
08/01/2026
Industria
Ciencia
Higiene alimentaria
Salud
Biología
Sanidad
Biotecnología
Farmacéutica
INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™
Fuente
1.00
11/11/2025
Veterinaria
Ciencia
Animales
Medicina - Varios
Sanidad
Biotecnología
Farmacéutica
Ir de compras
Salud
Mercado laboral
CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment
Fuente
1.00
11/11/2025
Mercado laboral
Veterinaria
Ciencia
Animales
Medicina - Varios
Sanidad
Biotecnología
Farmacéutica
Ir de compras
Salud
RION Launches Rion Vet to Transform Animal Health with First-in-Class Exosome Biologics; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment
Fuente
1.00
23/09/2025
Mercado laboral
Industria
Biotecnología
Farmacéutica
Sanidad
Salud
Ir de compras
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics
Fuente
1.00
09/09/2025
Cosmética
Sanidad
Venta al público/Minorista
Tecnología
Farmacéutica
Ciencia
Oncología
VIH, SIDA y enfermedades autoinmunes
Ir de compras
Biología
Técnica
Medicina - Varios
Biotecnología
Salud
Mercado laboral
Industria
RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appoints Biopharma Veteran Suneet Varma as CEO
Fuente
1.00
01/05/2025
Mercado laboral
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics
Fuente
1.00
11/03/2025
Industria
Biotecnología
Salud
Sanidad
Farmacéutica
Ciencia
Material médico sanitario
Medicina - Varios
RION Announces First Patient Enrolled in Phase 1b Clinical Study Evaluating Purified Exosome Product™ (PEP™) for Knee Osteoarthritis
Fuente
1.00
13/01/2025
Análisis de Mercados
Ciencia
Biotecnología
Farmacéutica
Medicina - Varios
Salud
VIH, SIDA y enfermedades autoinmunes
RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers
Fuente
1.00
07/01/2025
Eventos
Ciencia
Biotecnología
Farmacéutica
Salud
Material médico sanitario
RION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fuente
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0